2.32 (-%)
As of Nov 21, 2024
Source:
Alaunos Therapeutics, Inc is a clinical-stage oncology-focused cell therapy company developing adoptive TCR-T cell therapy, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs.
| Country | United States |
| Headquarters | houston, texas |
| Phone Number | (346) 355-4099 |
| Industry | manufacturing |
| CEO | Dale Curtis Hogue, Jr. |
| Website | www.alaunos.com |